AU2002356615A1 - Novel utilization of cyclopentabenzofurans - Google Patents

Novel utilization of cyclopentabenzofurans

Info

Publication number
AU2002356615A1
AU2002356615A1 AU2002356615A AU2002356615A AU2002356615A1 AU 2002356615 A1 AU2002356615 A1 AU 2002356615A1 AU 2002356615 A AU2002356615 A AU 2002356615A AU 2002356615 A AU2002356615 A AU 2002356615A AU 2002356615 A1 AU2002356615 A1 AU 2002356615A1
Authority
AU
Australia
Prior art keywords
cyclopentabenzofurans
novel utilization
utilization
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002356615A
Inventor
Lutz Assmann
Thomas Fahrig
Irene Gerlach
Martin Hendrix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002356615A1 publication Critical patent/AU2002356615A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
AU2002356615A 2001-11-29 2002-11-18 Novel utilization of cyclopentabenzofurans Abandoned AU2002356615A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10158561.6 2001-11-29
DE10158561A DE10158561A1 (en) 2001-11-29 2001-11-29 New use of cyclopentabenzofurans
PCT/EP2002/012880 WO2003045375A1 (en) 2001-11-29 2002-11-18 Novel utilization of cyclopentabenzofurans

Publications (1)

Publication Number Publication Date
AU2002356615A1 true AU2002356615A1 (en) 2003-06-10

Family

ID=7707368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002356615A Abandoned AU2002356615A1 (en) 2001-11-29 2002-11-18 Novel utilization of cyclopentabenzofurans

Country Status (3)

Country Link
AU (1) AU2002356615A1 (en)
DE (1) DE10158561A1 (en)
WO (1) WO2003045375A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10356218A1 (en) * 2003-12-03 2005-06-30 Bayer Cropscience Ag A method for identifying fungicidally active compounds based on pyruvate kinases from fungi
DE102004024504A1 (en) * 2004-05-18 2006-02-16 Bayer Healthcare Ag Novel cylopenta [b] benzofuran derivatives and their use
EP1693059A1 (en) * 2005-02-22 2006-08-23 Deutsches Krebsforschungszentrum Use of rocaglamide derivatives as NF-AT-specific inhibitors for the treatment of certain inflammatory diseases
EP2189158A1 (en) 2008-11-20 2010-05-26 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
EP2189453A1 (en) * 2008-11-25 2010-05-26 Université Louis Pasteur Rocaglaol derivatives as cardioprotectant agents
EP2457907A1 (en) 2010-11-16 2012-05-30 Université de Strasbourg Flavagline derivatives as neuroprotective agents
US20160287553A1 (en) 2013-11-22 2016-10-06 Deutsches Krebsforschungszentrum Translation inhibitors in high-dose chemo- and/or high-dose radiotherapy
CN113149942B (en) * 2021-02-10 2023-06-02 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) Rockwell alcohol phenolic hydroxyl derivative, preparation method and application thereof
CN115073407A (en) * 2021-03-10 2022-09-20 上海中医药大学 Medicinal composition with synthetic lethality and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835324A1 (en) * 1998-08-05 2000-02-10 Bayer Ag Cyclopentabenzofuran derivatives and their use
DE19835325A1 (en) * 1998-08-05 2000-02-10 Bayer Ag Use of cyclopentabenzofuran derivatives for the control of NF-kB dependent diseases
CA2404231A1 (en) * 2000-03-28 2001-10-04 Eli Lilly And Company Methods of treating diseases with activated protein c

Also Published As

Publication number Publication date
DE10158561A1 (en) 2003-06-12
WO2003045375A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002357860A1 (en) Enzymes
AU2002359165A1 (en) Novel compounds
AU2002359320A1 (en) Novel anit-infectives
AU2002314044A1 (en) Novel use of 2-phenyl-substituted imidazotriazinones
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2002347778A1 (en) Enzymes
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002257273A1 (en) Enzymes
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AUPR482001A0 (en) Metal-handling enzymes
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002253663A1 (en) Novel maxizyme
AU2002254979A1 (en) Novel sulfonylamino-pyrimidines
AU2002254880A1 (en) Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
AU2002238545A1 (en) Novel substituted imidazotriazinones
AU2002238802A1 (en) Realization of presence management
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
AU2002344927A1 (en) Novel uses of dl-thp
AU2002341119A1 (en) Use of oligomeric proanthrocyanidins
AU2001100522A4 (en) e-Trans
AU2001100338A4 (en) Sunglove
AU2001100214A4 (en) Dolly-trolley

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase